Locations:

Urology & Nephrology

January 13, 2020/Cancer

Metacure Trial: Can We Cure More Oligometastatic Prostate Cancer?

Study combines hormonal therapy with prostatectomy and radiation therapy of bone lesions

December 27, 2019/Cancer/Radiation Oncology

Testing the Ability to Preserve Erectile Function While Using Stereotactic Ablative Body Radiotherapy for Localized Prostate Cancer

Clinical trial investigates nerve-sparing approach

December 26, 2019/Urology & Nephrology/Nephrology

Virtual Reality Is Creating a New Learning Experience for Aspiring Nephrologists

How one nephrologist is enhancing renal physiology curricula

December 16, 2019/Urology & Nephrology/Urology

‘A Fitbit for the Bladder’: UroMonitor Takes Monitoring Out of the Clinic

Clinical trials for a urinary incontinence device are scheduled to begin soon

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Enrollment for two promising, multicenter kidney disease clinical trials is now underway

December 12, 2019/Urology & Nephrology/Research

Two Clinical Trials, One Ambitious Goal to Personalize Kidney Medicine

Two multicenter, NIH-sponsored trials began enrolling patients

December 3, 2019/Urology & Nephrology/Nephrology

ACE Inhibitor and ARB Therapy: Practical Recommendations

Cleveland Clinic nephrologist discusses best practices

A new study led by researchers in Cleveland Clinic's Department of Nephrology and Hypertension examines treatment-resistant hypertension in chronic kidney disease patients, utilizing both office blood pressure measurements and ambulatory blood pressure monitoring.

November 26, 2019/Urology & Nephrology/Nephrology

Rates of Treatment-Resistant Hypertension in Chronic Kidney Disease Patients is High, Study Finds

Ambulatory blood pressure monitoring confirms high prevalence of treatment-resistant hypertension in CKD

November 19, 2019/Urology & Nephrology/Nephrology

Infiltrative Renal Masses: More Common Than Previously Thought and Often Unrecognized

Study examines how infiltrative features affect prognosis

November 11, 2019/Cancer

Study Sheds New Light on the Role of Prohibitin in Wilms’ Tumor

Urine prohibitin identified as a prognostic biomarker in Wilms’ tumor

November 8, 2019/Urology & Nephrology/Nephrology

Cleveland Clinic’s Department of Nephrology and Hypertension Named Comprehensive Hypertension Center by the American Heart Association

One of only eight centers recognized nationally

BackPage 23 of 43Next